Eden Research Share Discussion Threads

[investingisatrickygame] 08/6/2020 12:44

Some decent buys coming through and yet no price movement. Where is the available stock coming from?

[attyg] 08/6/2020 07:19

Most amusing Super

[supersonico] 06/6/2020 10:33

Looking forward to the Companion animal news when Schools return in September.

[supersonico] 06/6/2020 07:16

Global Agricultural Productivity Reports ++Parked

[brucie5] 05/6/2020 12:08

Investingisatrickygame
3 Jun '20 - 11:02 - 7770 of 7779
0 3 1
There has been a lot of buying this last week or so. With Eden traditionally an illiquid stock, it can't be long before available stock is exhausted and the share price gets a leg up to another level, whatever that may be.
-----------------------------------------------------------
Agreed. Look at the chart. Sp. now remaining over the 200 simple ma; and gathering beautifully over the weighted mas. It may be partly a function of wider market strengths, but I believe we have passed inflexion point with the fundraise, and residual doubters getting off at or near the bottom.

So I added this morning at 8.50. The spread is never pleasant, but I believe it will be a whole lot higher by year's end.

[supersonico] 05/6/2020 11:54

First Quarter 2020 Results:

[quazie12] 04/6/2020 23:55

Who exactly SS ? "Sea of blue" ? The share price is static at 8p mid all day. Are you okay ?

[quazie12] 04/6/2020 23:53

CrischasIts incredible on here you have SS does more single handed to publicise and promote Eden than the BoD seem to do. But thats nothing new. What was an utter shock to me was the completely over the top Financial Statements the company produces. Around 100 pages ffs.20 years and still nothing approaching break even.

[supersonico] 04/6/2020 18:54

Glad it's not just me who can see the big Corteva picture and the quiet patent/IP evolution.
Perhaps they are also scratching their heads asking why Eden need two Rice special advisers.
Perhaps they even read post 7722.
Who knows but the sea of blue suggests to me they're not investing primarily in the hope of decent Mevalone or Cedroz numbers.

The game has changed.

[chrischas] 04/6/2020 15:11

Quazie 12:

I could not agree more .The whole BOD seems oblivious to sales.

In fact they are not driving sales with their distributors

Very few potential purchasers of the products have ever heard of the company or its product name.

[supersonico] 04/6/2020 14:58

Market analyses and briefs
These reports examine the evolution of global and EU agricultural markets

[quazie12] 04/6/2020 11:22

I cannot get into your link SS. Assume it was a slight in my comment re Sean Smith interview. I will be specific. If readers care to listen to the full interview in Proavtive Investors back in January 2020, in spite of the open ended questions inviting it, he dies not ONCE mention sales, potential sales, royalities in the entire 8 plus minute interview. Eden have been seeking regulatory approvals long before i first invested over 15 years ago. How can a CEO not mention the life blood of a business but once ? It beggars belief, truly does

[supersonico] 04/6/2020 09:02

Impact Company of the Year

[supersonico] 04/6/2020 07:22

There is a dark evil lurking..News

Court orders EPA approval of Bayer dicamba herbicide vacated; says regulator “understated the risks”

The court found@EPA refused to estimate the
amount of dicamba damage, characterizing such damage as “potential” and “alleged,” when record evidence showed that dicamba had caused substantial and
undisputed damage

In overturning @EPA approval of dicamba herbicides by @Bayer@BASF& @corteva
court says it knows farmers who already bought GMO seed and herbicides will be hurt & says farmers "have been placed in this situation through no fault of their own."

carey gillam@careygillam

[investingisatrickygame] 03/6/2020 11:02

There has been a lot of buying this last week or so. With Eden traditionally an illiquid stock, it can't be long before available stock is exhausted and the share price gets a leg up to another level, whatever that may be.

[supersonico] 03/6/2020 08:00

There is a dark evil lurking.

This will not surprise those who followed the Glyphosate Discovery process ... News

[supersonico] 02/6/2020 18:31

Corteva CEO on the state of seed, crop protection business.

[supersonico] 02/6/2020 18:18

India Chemical Seed Treatment​ Market Insights.

Seed treatment can be defined as the application of chemical ingredients or biological organisms to the seed that enables in suppressing, controlling or repelling plant pathogens, insects, or other pests that attack seeds, seedlings or plants. The India Chemical seed treatment market was worth around USD 119.9 million in 2016 and is expected to cross USD 220.7 million by 2022 growing at the CAGR of 10.7% during the forecast period 2017-2022.
Market Dynamics

The growth in seed treatment industry is largely fuelled by increasing farm sizes and rising concerns over its quality and safety due to harmful effects of chemicals to environment. Thus, some major drivers of the seed treatment industry are rise in the seed costs, crop rotations getting shorter and greater use of multi-component products. The poor farmers in India are adopting organic techniques which have a lower environment impact which is driving the market.

Major restraints identified in this report are regulatory structure intervention regarding entry, concerns for the environment and regulation of seed treatment market. Major opportunities are fastest growth rate for biological agents and India has a fastest growth rate in seed treatment market.

India market holds 34% of the Asia-Pacific market revenue by 2022. The India market is expected to have a high CAGR of 10.8% due to increasing demand for high yield crop products in the region and rising organic crop production, especially in China, India, Malaysia, Japan and Singapore.

Within this application category, insecticides constitute the largest sub-category, with an estimated 2015 share of 56.3% of chemical seed treatment demand. However, fungicide seed treatments are slated to witness the fastest CAGR of 11.4% during 2017-2022 in reaching a projected demand of USD 79.2 million by 2022.

India total oilseed production, comprising soybeans, rapeseed, mustard, peanuts, sunflower seed, cottonseed and copra, is forecast to be 37.4 million metric tons (MMT) for the marketing year (MY) 2014-15 (October to September), which forma a decline of 2.5% from the current year, assuming that monsoons are normal for the period of June 2014 to September 2014. India consumption of oilseed-based food products is poised to register steady growth and reach 1.9 MMT in MY 2014-15. The primary driver for this impetus would come from robust growth in the food processing sector and increasing marketability for higher-value food products made from soybeans, peanuts, rapeseed, mustard, and other oilseeds. As a consequence of growing domestic demand, exports of oilseeds in the current and future years are likely to slow down their previous pace of growth.

Wheat is the leading type of crop for chemical seed treatment applications in India, estimated to account for 34.9% of the total demand in 2016. In terms of CAGR between 2017 and 2022, however, demand for seed treatment applications in corn is expected to be the second fastest crop among all crop types at 10% CAGR, Asia remains the hub of rice production, with many countries in the region growing more than one crop per season.

Key Industry Players
Some of the key companies in the market are Adama, Novozymes, Chemtura, Syngenta and Others. The key players are focusing to expand their business in Asia-Pacific regions. The leading players in this market adopted various strategies to strengthen the market opportunities and increase their market shares. Acquisitions, agreements & joint ventures are the major strategies adopted by major players.

[supersonico] 02/6/2020 08:11

Goodness Gracious Me

[chrischas] 01/6/2020 17:35

Do you think the BODs could have used this as a template BEFORE the beginning of this year’s growing season. Come to think of it they probably have not even seen how Lower paid Sipcam employees can boost a product.

[33mick] 01/6/2020 15:31

Need a granular researcher to make sense of this lot..
it's basically a French field test of existing bio Botryis products...Edens existing competition...Mevalone is very briefly mentioned but not tested..gotta love the French..paper states out of 6 bacteria based products only one showed any promise..and more research required!

ORIGINAL RESEARCH ARTICLE
Front. Plant Sci., 11 February 2019 | hxxps://doi.org/10.3389/fpls.2019.00105
Microbial Antagonism Toward Botrytis Bunch Rot of Grapes in Multiple Field Tests Using One Bacillus ginsengihumi Strain and Formulated Biological Control Products

[quazie12] 01/6/2020 15:01

Just don't know what else would possibly encourage buyers

[quazie12] 01/6/2020 14:59

More likely a leak than a cleared seller